top of page
Browse by category
Search
Extreme weight fluctuation increases risk of death for PLWO
New research has found for the first time that extreme weight fluctuations in people living with obesity (PLWO) and cardiovascular...
FDA approves semaglutide to reduce the risk of worsening kidney disease and cardiovascular death
The FDA has approved Ozempic to reduce the risk of kidney disease worsening, kidney failure (end-stage kidney disease) and death due to...
AOMs result in 8% relative risk reduction in any CVD events in patients with obesity
The utilisation of anti-obesity medications (AOMs) among people with obesity could potentially alleviate the high prevalence of...
FDA approves Wegovy for CVD risk reduction in people with overweight or obesity and established cardiovascular disease
The FDA has approved a label expansion for Wegovy based on a supplemental New Drug Application (sNDA) for the indication of reducing...
Ultra-processed foods increase the risk of all-cause mortality and to 32 damaging health outcomes
Highly suggestive (class II) evidence indicates that higher exposure to ultra-processed foods is associated with an increased risk of 32...
Bariatric surgery can impair midwall left ventricular dysfunction in certain patients one-year after surgery
Patients with severe obesity and in particular women with hypertension, higher level of inflammation and reduced ejection fraction, have...
Bariatric surgery reverses remodelling and improvement in cardiac geometry and function
Bariatric surgery leads to reverse remodelling and improvement in cardiac geometry and function driven by metabolic and haemodynamic...
Bariatric surgery associated with significant reduction in CVD risk in patients with severe obesity
Researchers from the Ohio State University, Columbus, OH, have report that bariatric surgery, compared with nonsurgical care, was...
Browse by tag
bottom of page